Your browser doesn't support javascript.
loading
Assessing the Immunosafety of Engineered Nanoparticles with a Novel in Vitro Model Based on Human Primary Monocytes.
Li, Yang; Italiani, Paola; Casals, Eudald; Valkenborg, Dirk; Mertens, Inge; Baggerman, Geert; Nelissen, Inge; Puntes, Victor F; Boraschi, Diana.
Afiliação
  • Li Y; Institute of Protein Biochemistry, National Research Council , 80131 Napoli, Italy.
  • Italiani P; Institute of Protein Biochemistry, National Research Council , 80131 Napoli, Italy.
  • Casals E; Institut Català de Nanotecnologia , Campus of the UAB, 08193 Bellaterra, Spain.
  • Valkenborg D; Flemish Institute for Technological Research , 2400 Mol, Belgium.
  • Mertens I; Center for Proteomics, University of Antwerp , 2020 Antwerp, Belgium.
  • Baggerman G; Flemish Institute for Technological Research , 2400 Mol, Belgium.
  • Nelissen I; Center for Proteomics, University of Antwerp , 2020 Antwerp, Belgium.
  • Puntes VF; Flemish Institute for Technological Research , 2400 Mol, Belgium.
  • Boraschi D; Center for Proteomics, University of Antwerp , 2020 Antwerp, Belgium.
ACS Appl Mater Interfaces ; 8(42): 28437-28447, 2016 Oct 26.
Article em En | MEDLINE | ID: mdl-27670583

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Monócitos Idioma: En Ano de publicação: 2016 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Monócitos Idioma: En Ano de publicação: 2016 Tipo de documento: Article